Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Exosomes from skin cells can boost hair growth by stimulating a gene called LEF1.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Oral contraceptives may cause hair loss in women.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Lower SHBG levels may increase the risk of PCOS.

Neurosteroids show promise for treating epilepsy and more research is needed.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Resistance training might help with PCOS symptoms, but more research is needed.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.